November 2024

NEWS & COLUMNS

6-7 NEWS
Astellas and AviadoBio in $2bn deal; AbbVie’s continuous Parkinson’s therapy approved by FDA

8-9 NEWS
Eli Lilly's results for Alzheimer’s drug; NHS England begins newborn screening programme

10-11 DERMATOLOGY NEWS
Ipsen’s Kayfanda approved by EC; LEO Pharma's final results for atopic dermatitis

12 DARWIN'S MEDICINE
Avoiding simplicity with complex problems

13 ALL HANDS ON DECK
We all need to push harder towards environmental sustainability goals

14 INNOVATIVE IMPACT
Bridging gaps and breaking barriers in pharma alliances

15 HEALTH EQUITY
Achieving health equity is a multidimensional challenge

FEATURES

16-17 WHY THE PATIENT VOICE IS THE SECRET TO RE-ENERGISING THE HEALTHCARE SECTOR
The challenges facing the UK’s healthcare system and why putting the patient voice at the heart of our work is key. If we want to retain and recruit the best people into the healthcare sector, we need to think about how we approach our work

18-19 HOW THE ‘FIVE PS’ CAN CLOSE HEALTH EQUITY GAPS
In Europe, health inequity poses the greatest challenge to achieving public health goals in the coming years. Policymakers, payers, providers, patients and pharma are each uniquely able to impact health equity – and together, achieve real progress

20-22 ENABLING A SUSTAINABLE AND MUTUALLY BENEFICIAL CDMO PARTNERSHIP
There are a multitude of CDMO options available, all providing specialised expertise and solutions for diverse and complex activities